Hypergastrinemia and mortality in gastric adenocarcinoma: a population-based cohort study, the HUNT study

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Jimenez Fonseca P, Carmona-Bayonas A, Hernandez R, et al. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. Br J Cancer. 2017;117(6):775–782.
   PubMed Web of Science ®Google Scholar
• Bringeland EA, Wasmuth HH, Fougner R, et al. Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery. Br J Surg. 2014;101(13):1712–1720.
   PubMed Web of Science ®Google Scholar
• Bringeland EA, Wasmuth HH, Johnsen G, et al. Outcomes among patients treated for gastric adenocarcinoma during the last decade. J Surg Oncol. 2013;107(7):752–757.
   PubMed Web of Science ®Google Scholar
• Bringeland EA, Wasmuth HH, Mjones P, et al. A population-based study on incidence rates, Lauren distribution, stage distribution, treatment, and long-term outcomes for gastric adenocarcinoma in Central Norway 2001–2011. Acta Oncol. 2017;56(1):39–45.
   PubMed Web of Science ®Google Scholar
• Helicobacter; Cancer Collaborative G. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49(3):347–353.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Rabkin CS, Turner N, et al. The changing face of noncardia gastric cancer incidence among US Non-hispanic Whites. J Natl Cancer Inst. 2018;110(6):608–615.
   PubMedGoogle Scholar
• Arnold M, Park JY, Camargo MC, et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823–829.
   PubMed Web of Science ®Google Scholar
• Bergquist JR, Leiting JL, Habermann EB, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery. 2019;166(4):547–555.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Wahlin K, Engstrand L, et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. 2017;7(10):e017739.
   PubMed Web of Science ®Google Scholar
• Waldum HL. The increase in early-onset gastric carcinomas from 1995 is probably due to the introduction of proton pump inhibitors. Surgery. 2020;168(3):568–569.
   PubMed Web of Science ®Google Scholar
• Strickland RG. The Sydney system: auto-immune gastritis. J Gastroenterol Hepatol. 1991;6(3):238–243.
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Di Mario F, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15(12):1833–1843.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Hauso O, Sordal OF, et al. Gastrin may mediate the carcinogenic effect of Helicobacter pylori infection of the stomach. Dig Dis Sci. 2015;60(6):1522–1527.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Hauso O, Fossmark R. The regulation of gastric acid secretion – clinical perspectives. Acta Physiol (Oxf). 2014;210(2):239–256.
   PubMed Web of Science ®Google Scholar
• Walsh JH, Richardson CT, Fordtran JS. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest. 1975;55(3):462–468.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Sandvik AK, Brenna E, et al. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut. 1991;32(6):698–701.
   PubMed Web of Science ®Google Scholar
• Oettle AG. Spontaneous carcinoma of the glandular stomach in Rattus (mastomys) natalensis, an African rodent. Br J Cancer. 1957;11(3):415–433.
   PubMed Web of Science ®Google Scholar
• Poynter D, Pick CR, Harcourt RA, et al. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut. 1985;26(12):1284–1295.
   PubMed Web of Science ®Google Scholar
• Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion. 1986;35(Suppl 1):42–55.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Sandvik AK, Brenna E. Gastrin, the enterochromaffin like cell, and gastric tumors. Gastroenterology. 1993;105(4):1264–1266.
   PubMed Web of Science ®Google Scholar
• Honda S, Fujioka T, Tokieda M, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998;58(19):4255–4259.
   PubMed Web of Science ®Google Scholar
• Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000;118(1):36–47.
   PubMed Web of Science ®Google Scholar
• Martinsen TC, Kawase S, Hakanson R, et al. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis. 2003;24(12):1887–1896.
   PubMed Web of Science ®Google Scholar
• Ness-Jensen E, Bringeland EA, Mattsson F, et al. Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: a prospective population-based nested case-control study. Int J Cancer. 2021;148(8):1879–1886.
   PubMed Web of Science ®Google Scholar
• Fossmark R, Sagatun L, Nordrum IS, et al. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. APMIS. 2015;123(6):509–514.
   PubMed Web of Science ®Google Scholar
• Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT Study, Norway. Int J Epidemiol. 2013;42(4):968–977.
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction – classification, pathology and extent of resection. Dis Esophagus. 1996;9(3):173–182.
   Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
   PubMedGoogle Scholar
• Rehfeld JF, Gingras MH, Bardram L, et al. The Zollinger–Ellison syndrome and mismeasurement of gastrin. Gastroenterology. 2011;140(5):1444–1453.
   PubMed Web of Science ®Google Scholar
• TNM Classification of Malignant Tumours. Union for international cancer control. 7th ed. New York (NY): Wiley.
   Google Scholar
• Rehfeld JF. Gastrin and the moderate hypergastrinemias. Int J Mol Sci. 2021;22(13):6977.
   PubMed Web of Science ®Google Scholar
• Lichtenberger LM, Graziani LA, Dubinsky WP. Importance of dietary amines in meal-induced gastrin release. Am J Physiol. 1982;243(5):G341–G347.
   PubMed Web of Science ®Google Scholar
• Bakke I, Qvigstad G, Sandvik AK, et al. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol. 2001;36(11):1128–1133.
   PubMed Web of Science ®Google Scholar
• Qvigstad G, Qvigstad T, Westre B, et al. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS. 2002;110(2):132–139.
   PubMed Web of Science ®Google Scholar
• Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med. 2010;362(22):2053–2065.
   PubMed Web of Science ®Google Scholar
• Mastracci L, Rindi G, Grillo F, et al. Neuroendocrine neoplasms of the esophagus and stomach. Pathologica. 2021;113(1):5–11.
   PubMed Web of Science ®Google Scholar
• Kim Y, Spolverato G, Ejaz A, et al. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma. Ann Surg Oncol. 2015;22(6):1828–1835.
   PubMed Web of Science ®Google Scholar
• Yin X, Fang T, Wang Y, et al. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer. Cancer Med. 2021;10(3):1103–1119.
   PubMed Web of Science ®Google Scholar
• Messager M, Lefevre JH, Pichot-Delahaye V, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254(5):684–693. discussion 693.
   PubMed Web of Science ®Google Scholar
• Iyer P, Moslim M, Farma JM, et al. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol. 2020;5:52.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas ResearchN. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–209.
   PubMed Web of Science ®Google Scholar
• Sohn BH, Hwang JE, Jang HJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23(15):4441–4449.
   PubMed Web of Science ®Google Scholar